Expiration date: 06/2026

Composition and form of issue:

Oral solution. 100 ml contains:

Ginkgo biloba dry standardized extract (EGb 761) 4000, 00 mg

(the contents of heterosides Ginkgo — 24% of ginkgolides-bilobalides — 6% ) 

excipients: sodium saccharinate orange essence soluble lemon essence soluble ethanol (95%), purified water-up to 100 ml 

in dark glass bottles of 30 ml (complete with dosing pipette) in a pack of cardboard 1 bottle.

Tablets, film-coated. 1 tablet contains:

Ginkgo biloba dry standardized extract (EGb 761) 40, 00 mg

(the contents of heterosides Ginkgo — 24% of ginkgolides-bilobalides — 6% ) 

Excipients:

core: lactose monohydrate microcrystalline maize starch silica colloidal anhydrous talc magnesium stearate 

shell: hypromellose macrogol 400 macrogol 6000 titanium dioxide iron oxide red 

in packages of contour cell 15 PCs. in a pack of cardboard 2 or 6 packages.

Description of dosage form:

Oral solution-brownish-orange with a characteristic smell.

Tablets, film-coated, — biconvex, round, film-coated brick red colour.

At the break of the tablets have a light brown color and a specific smell.

Characteristic:

Standardized and titrated drug of plant origin, the effect of which is due to the influence on the metabolic processes in cells, rheological properties of blood, as well as vasomotor reactions of blood vessels.

Description of pharmacological action:

Improves the supply of oxygen to the brain and glucose, normalizes the tone of arteries and veins, improves microcirculation, improves blood flow, prevents the aggregation of red blood cells has an inhibitory effect on platelet-activating factor improves metabolic processes, has antihypoxia effect on tissue and prevents the formation of free radicals and lipid peroxidation of cell membranes affects the release, reuptake and catabolism of neurotransmitters (norepinephrine, acetylcholine) and their ability to bind with membrane receptors.

Indications:

• cognitive and neurosensory deficits of different Genesis (except for Alzheimer's disease and dementia of different etiology)
  
• intermittent claudication with chronic obliterating arteriopathy lower extremities (2nd degree according to Fontaine)
  
• vision disorders of vascular origin, the reduction of its severity
  
• hearing impairment, tinnitus, dizziness and coordination disorders mainly of vascular origin
  
• Raynaud's disease and syndrome.
  

Contraindications:

• hypersensitivity to any of the components of the drug
  
• pregnancy and lactation (due to lack of clinical data).
  

Since the drug in the form of tablets contains lactose, it can not be prescribed to patients with congenital galactosemia, malabsortion syndrome of glucose or galactose, or lactase deficiency.

Use during pregnancy and breast-feeding:

Contraindicated in pregnancy. At the time of treatment should stop breastfeeding.

Side effect:

Rarely-digestive disorders, skin allergic reactions, headaches, dizziness, insomnia.

Drug interaction:

Due to the fact that the drug in the form of a solution contains 0, 45 g 57% ethyl alcohol per dose (one dose), it is necessary to avoid simultaneous use with drugs of the following groups due to the possible occurrence of such reactions as hyperthermia, skin hyperemia, increased heart rate: antibiotics-cephalosporins (cefamandol, cefoperazone, latamoxef) disulfiram chloramphenicol antidiabetic hypoglycemic agents (cephalosporin). chlorpropamide, glibenclamide, glipizid, butamide) fungicides (griseofulvin) 5-nitroimidazoles (metronidazole, Ornidazole, secnidazole, tinidazole), ketoconazole cytotoxic agents (procarbazine) tranquilizers.

Dosage and administration:

Inside, eating.

1 table. or 1 ml of solution 3 times a day. The solution for oral administration should be pre-dissolved in 1/2 Cup water. Tablets should be washed down with 1/2 Cup water.

When taking the drug in the form of a solution for oral administration, use the supplied pipette-dispenser (1 dose = 1 ml of solution).

Overdose:

Cases of drug overdose are not known.